学术探索
学术期刊
新闻热点
数据分析
智能评审

The mechanisms of action of rituximab in the elimination of tumor cells

被引：202
作者：
Johnson, P [1 ]
Glennie, M [1 ]
机构：
[1] Univ Southampton, Sch Med, Canc Sci Div, Southampton, Hants, England
来源：
SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 01期
关键词：
D O I：
10.1053/sonc.2003.50025
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3 / 8
页数：6
相关论文
共 35 条
  • [1] Alas S, 2000, ANTICANCER RES, V20, P2961
  • [2] Alas S, 2001, CANCER RES, V61, P5137
  • [3] Alas S, 2001, CLIN CANCER RES, V7, P709
  • [4] Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma
    Anderson, DR
    GrilloLopez, A
    Varns, C
    Chambers, KS
    Hanna, N
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) : 705 - 708
  • [5] TRANSFECTION OF THE CD20 CELL-SURFACE MOLECULE INTO ECTOPIC CELL-TYPES GENERATES A CA2+ CONDUCTANCE FOUND CONSTITUTIVELY IN B-LYMPHOCYTES
    BUBIEN, JK
    ZHOU, LJ
    BELL, PD
    FRIZZELL, RA
    TEDDER, TF
    [J]. JOURNAL OF CELL BIOLOGY, 1993, 121 (05) : 1121 - 1132
  • [6] The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction
    Byrd, JC
    Kitada, S
    Flinn, IW
    Aron, JL
    Pearson, M
    Lucas, N
    Reed, JC
    [J]. BLOOD, 2002, 99 (03) : 1038 - 1043
  • [7] Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
    Cartron, G
    Dacheux, L
    Salles, G
    Solal-Celigny, P
    Bardos, P
    Colombat, P
    Watier, H
    [J]. BLOOD, 2002, 99 (03) : 754 - 758
  • [8] Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
    Clynes, RA
    Towers, TL
    Presta, LG
    Ravetch, JV
    [J]. NATURE MEDICINE, 2000, 6 (04) : 443 - 446
  • [9] Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden:: clinical and molecular evaluation
    Colombat, P
    Salles, G
    Brousse, N
    Eftekhari, P
    Soubeyran, P
    Delwail, V
    Deconinck, E
    Haïoun, C
    Foussard, C
    Sebban, C
    Stamatoullas, A
    Milpied, N
    Boué, F
    Taillan, B
    Lederlin, P
    Najman, A
    Thièblemont, C
    Montestruc, F
    Mathieu-Boué, A
    Benzohra, A
    Solal-Céligny, P
    [J]. BLOOD, 2001, 97 (01) : 101 - 106
  • [10] Rituximab in combination with CHOP or fludarabine in low-grade lymphoma
    Czuczman, MS
    Fallon, A
    Mohr, A
    Stewart, C
    Bernstein, ZP
    McCarthy, P
    Skipper, M
    Brown, K
    Miller, K
    Wentling, D
    Klippenstein, D
    Loud, P
    Rock, MK
    Benyunes, M
    Grillo-López, AJ
    Bernstein, SH
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (01) : 36 - 40
1234